Classification, Symptoms, Treatment and Preventive Strategies of Diabetes. A guide to the basic
DOI:
https://doi.org/10.12775/JEHS.2024.70.50192Keywords
diabetes, clinical symptoms, obesity, diabetes-related complicationsAbstract
Introduction
Diabetes is a chronic metabolic disorder characterized by impaired insulin secretion and action. Risk factors for diabetes include age, obesity, low physical activity, hypertension, lipid disorders, and genetic predisposition. Symptoms of diabetes typically include frequent urination, weight loss, excessive thirst, weakness, fatigue, susceptibility to fungal infections and recurrent boils. Diabetes is a prevalent and significant societal concern, often causing anxiety, uncertainty and a sense of danger upon diagnosis.
Aim of the study
The aim of the study is to provide a comprehensive analysis of diabetes, including its classification, characteristic symptoms, the most frequently occurring diabetes-related complications, and preventive strategies. Through a detailed discussion of these issues, our goal is to increase public awareness of diabetes and provide readers with comprehensive knowledge about this disease.
Material and method
This article presents the current state of knowledge about diabetes. A literature review was conducted using the PubMed, Google Scholar and Web of Science databases, utilizing keywords such as "diabetes", "diabetes mellitus", "diabetes complications".
Results
The number of people with diabetes has continued to rise. Scientists predict that in a few decades, this number could reach more than half a billion globally. Many individuals may not realize that they are at risk for this civilization disease, often due to unhealthy lifestyle choices such as smoking, obesity, and lack of physical activity. Early initiation of treatment is crucial in preventing serious complications. Despite living with diabetes for years, some patients still report insufficient knowledge about their condition. Therefore, educating patients about the nature of the disease and its treatment is essential for improving their quality of life.
References
Wender-Ożegowska E, Bomba-Opoń D, Brązert J, Czajkowski K, Celewicz Z, Gutaj P, et al. The Polish Society of Gynaecologists and Obstetricians standards for the management of patients with diabetes. Gynaecology and Practical Perinatology. 2017;2(5):215-229
Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, Budzyński A, Cyganek K, Cypryk K, et al. 2023 Guidelines on the management of patients with diabetes - a position of Diabetes Poland. Current Topics in Diabetes 2023;3(1):1-133. https://doi.org/10.5114/ctd/160061
Souto S, Campos J, Fanugeiro J, Silva A, Cicero N, Lucarni M, at al. Multiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection. Int J Mol Sci. 2020; 21(2): 645. https://doi.org/10.3390/ijms21020645
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(1):15–33. https://doi.org/10.2337/dc21-S002
Cosentino F, Grant P, Aboyans V, Bailey C, Ceriello A, DelgadoV, at al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), European Heart Journal. 2020;41(2):255–323. https://doi.org/10.1093/eurheartj/ehz486
Rahman M, Hossain K, Das S, Kundu S, Adegoke E, Rahman M, at al. Role of Insulin in Health and Disease: An Update. Int. J. Mol. Sci. 2021; 22(12): 6403. https://doi.org/10.3390/ijms22126403
Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw. 2016;70:1245-1257
NCD Risk Factor Collaboration and others. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4. 4 million participants. The Lancet. 2016;387(10027):1513-1530. https://doi.org/10.1016/S0140-6736(16)00618-8
OECD and European Union. Health at a Glance: Europe 2018. Health Status. 2018. p106. https://doi.org/10.1787/health_glance_eur-2018-en
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. The Lancet. 2010; 375:2215–2222. https://doi.org/10.1016/S0140-6736(10)60484-9
Walicka M, Raczyńska M, Marcinkowska K, Lisicka I, Czaicki A, WierzbaW, et al. Amputations of Lower Limb in Subjects with Diabetes Mellitus: Reasons and 30-Day Mortality. Journal of Diabetes Research. 2021. https://doi.org/10.1155/2021/8866126
Skupień J, Małecki M. Expanding diabetes classification — new subtypes and therapeutic options. Practical Diabetology. 2007; 8(1):1–12
Cypryk K. Gestational diabetes - diagnosis and treatment. Gynaecology and Practical Perinatology. 2016;1(2):41-44
Fowler M. J. Diabetes: scale of the problem and mechanisms. Clinical Diabetes. 2010; 7(2):41-46
Myśliwiec M. Diabetes in children - aetiopathogenesis, diagnosis and therapy. Forum of Family Medicine. 2007;1(2):125-133
Jankowiak B, Krystoń-Serafin M, Krajewska-Kułak E, Popławska E. Complications of diabetes as a chronić disease. Medical News. 2007;76(6):482-484
Jewusiak-Rogulska M, Kocięcki J. Epidemiology, clasification and innovative therapies of diabetic retinopathy. Medical News. 2013;82(3):253–258
Witek P. Algorithms of treatment in the diabetic neuropathy. Practical Diabetology. 2009;10(5):186–195
Pawlik D, Radziszewsk R. The maternal diabetes mellitus and consequences for newborn. Pediatric Endocrinology. 2015;14(1):43-51. https://doi.org/10.18544/EP-01.14.01.1510
American Diabetes Association Professional Practice Committee. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(1)S17–38. https://doi.org/10.2337/dc22-S002
ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D, at al. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(1):19–40. https://doi.org/10.2337/dc23-S002
Fowler M. J. Treatment of diabetes: oral medication antidiabetic. Clinical Diabetes. 2010;7(4): 30-33
Otto-Buczkowska E, Jarosz-Chobot P, Tucholski K. New developments in the treatment of type 1 diabetes mellitus. Polish Journal of Endocrinology. 2008; 59(3):246-253
Foltyn A. Diabetes type of LADA. Practical Diabetology. 2008; 9(5):220–226
Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management. Nurs Stand. 2022;37(1):61-66. https://doi.org/10.7748/ns.2021.e11709
Fayfman M, Pasquel F, Umpierrez G. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am. 2017;101(3):587-606. https://doi.org/10.1016/j.mcna.2016.12.011
Ramrakha P, Moore K, Sam A. Diabetes and endocrine emergencies. Oxford Handbook of Acute Medicine. 2019; 545–606. https://doi.org/10.1093/med/9780198797425.003.0009
Kerner W, Brückel J. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2014; 122(7): 384-386. http://dx.doi.org/10.1055/s-0034-1366278
Ho Moon J, Chul Jang H. Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications. Diabetes Metab J. 2022;46(1):3-14. https://doi.org/10.4093/dmj.2021.0335
Stompór T, Adamczak M, Masajtis-Zagajewska A, Mazanowska O, Maziarska K, Witkowska A, et al. Diagnosis and treatment of type 2 diabetes mellitus in patients with chronic kidney disease and eGFR < 60 mL/min — a position statement of the Polish Society of Nephrology Working Group on Metabolic and Endocrine Disorders in Kidney Diseases. Endokrynol Pol. 2020;71(1):3-14. http://dx.doi.org/10.5603/EP.a2019.0064
Aldhaeefi M, Aldardeer N, Alkhani N, Alqarni S, AlhammadA, Alshaya A. Updates in the Management of Hyperglycemic Crisis. Front Clin Diabetes Healthc. 2021; 2: 820728. https://doi.org/10.3389/fcdhc.2021.820728
Sibony R, Segev O, Dor S, Raz I. Drug Therapies for Diabetes. Int. J. Mol. Sci. 2023; 24(24). https://doi.org/10.3390/ijms242417147
Padhi S, Nayak A, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. 2020; 131.110708. https://doi.org/10.1016/j.biopha.2020.110708
Parab P, Chaudhary P, Mukhtar S, Moradi A, Kodali A, Okoye C, at al. Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiovascular Risk Management in Patients With Type 2 Diabetes Mellitus: A Systematic Review. Cureus. 2023; 15(9): e45487. http://dx.doi.org/10.7759/cureus.45487
Kelly M, Lewis J, Rao H, Carter J, Portillo I, Beuttler R. Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis. Pharmacotherapy. 2022; 42(12): 921–928. http://dx.doi.org/10.1002/phar.2737
Georgiou P, Johnston D. Guest Editorial Biomedical and Health Informatics for Diabetes. IEEE J Biomed Health Inform. 2016;20(1):3. http://dx.doi.org/10.1109/JBHI.2015.2504638
Walicka M, Chomiuk T, Filipiak K, Mamczarz A, Olszanecka-Glinianowicz M, Wożakowska-Kapłon B, et al. Type 2 diabetes prevention. Experts' Group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. Card Pol. 2015; 73(10): 949–957. http://dx.doi.org/10.5603/KP.2015.0183
Hamasaki H. Daily physical activity and type 2 diabetes: A review. World J Diabetes. 2016; 7(12): 243–251. http://dx.doi.org/10.4239/wjd.v7.i12.243
Uusitupa M, Khan T, Viguiliouk E, Kahleova H, Rivellese A, Hermansen K. Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis. Nutrients. 2019;11(11):2611. http://dx.doi.org/10.3390/nu11112611
Weber M, Hassan S, Quarells S, Shah M. Prevention of Type 2 Diabetes. Endocrinol Metab Clin North Am. 2021;50(3):387-400. https://doi.org/10.1016/j.ecl.2021.05.003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Magda Madoń, Patrycja Proszowska, Daria Sieniawska, Adrianna Orzeł, Aleksandra Pich-Czekierda, Zuzanna Kotowicz, Julia Sieniawska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 232
Number of citations: 0